DRL launches generic sofosbuvir & velpatasvir tablets for HCV in India
Posted on15 May 2017
TagsDr. Reddy’s Laboratories, DRL, Sofosbuvir, sofosbuvir & velpatasvir tablets, sofosbuvir/velpatasvir/voxilaprevir
Comments0
Dr Reddy’s Laboratories has launched the generic version of sofosbuvir 400mg and velpatasvir 100mg fixed-dose combination, indicated for the treatment of chronic... Read More
Gilead gets Indian patent for Hepatitis C drug Solvadi
Brand Name: Sovaldi Molecule: Sofosbuvir Innovator Company: Gilead Sciences In direct contradiction to its earlier order, the Controller General of Patents, Designs... Read More
ZydusCadila to launch Gilead’s Sovaldi in India
Posted on20 Mar 2015
TagsSofosbuvir, Sovaldi, Zydus biosimilar, Zydus Gliead deal, Zydus Heptiza, ZydusCadila to launch Gilead's Sovaldi in India
Comments0
The two companies have entered into a generic, non-exclusive licensing agreement to manufacture Sofobuvir and an investigational single tablet regime of Ledipasvir/... Read More
Natco launched first generic version of Sofosbuvir in Nepal
Posted on11 Mar 2015
Comments0
Natco Pharma has launched the first generic version of Sofosbuvir in Nepal. Sofosbuvir is a medicine used for chronic hepatitis C infection... Read More